Literature DB >> 8190478

Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor.

E D Donnenfeld1, A Schrier, H D Perry, T Aulicino, M E Gombert, R Snyder.   

Abstract

PURPOSE: To determine the intraocular penetration of topically applied fluoroquinolone antibiotics into aqueous humor.
METHODS: Thirty-two patients undergoing cataract extraction received either 0.3% ciprofloxacin, 0.3% norfloxacin, or 0.3% ofloxacin topical drops. The patients were given two drops 90 minutes preoperatively and two drops 30 minutes preoperatively. At the time of surgery, 0.1 ml aqueous fluid was aspirated from the anterior chamber and immediately stored at -70 degrees C.
RESULTS: Concentrations of ciprofloxacin, norfloxacin, and ofloxacin were determined using a broth dilution bioassay. Morganella morganii with a known minimal inhibitory concentration was used to assay ciprofloxacin and norfloxacin levels. Salmonella enteritidis with a known minimal inhibitory concentration was used to assay ofloxacin levels. Topically applied ciprofloxacin achieved a mean aqueous level of 0.072 microgram/ml (range, 0.02-0.153 microgram/ml). One sample was below the sensitivity of the bioassay. Topical norfloxacin achieved a mean aqueous level of 0.0570 microgram/ml (range, 0.046-0.10 microgram/ml). Seven samples did not reach the sensitivity of the bioassay. Topical ofloxacin achieved a mean level in the aqueous humor of 0.338 microgram/ml (range, 0.078-0.625 microgram/ml). There was no statistically significant difference in intraocular aqueous humor levels of ciprofloxacin versus norfloxacin (P > 0.05). Topical ofloxacin achieved aqueous humor levels significantly higher than either ciprofloxacin or norfloxacin (P < 0.004).
CONCLUSION: Of the currently available topical fluoroquinolone antibiotics, ofloxacin achieves the highest aqueous humor concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190478     DOI: 10.1016/s0161-6420(13)31248-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

Review 1.  Comparative review of topical ophthalmic antibacterial preparations.

Authors:  P Y Robert; J P Adenis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.

Authors:  Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2010-06-01       Impact factor: 3.421

3.  Strategies for the management of microbial keratitis.

Authors:  B D Allan; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

Review 4.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

Review 5.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

6.  Sparfloxacin-associated corneal epithelial toxicity.

Authors:  Aniruddha Kishandutt Agarwal; Jagat Ram; Ramandeep Singh
Journal:  BMJ Case Rep       Date:  2014-09-19

Review 7.  Fluoroquinolones: place in ocular therapy.

Authors:  A Smith; P M Pennefather; S B Kaye; C A Hart
Journal:  Drugs       Date:  2001       Impact factor: 9.546

8.  Bacterial keratitis: a prospective clinical and microbiological study.

Authors:  F Schaefer; O Bruttin; L Zografos; Y Guex-Crosier
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

9.  Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.

Authors:  N Morlet; G G Graham; B Gatus; A J McLachlan; C Salonikas; D Naidoo; I Goldberg; C M Lam
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.

Authors:  Emilia Ghelardi; Arianna Tavanti; Paola Davini; Francesco Celandroni; Sara Salvetti; Eva Parisio; Enrico Boldrini; Sonia Senesi; Mario Campa
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.